CELZ Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
3.0K
3.0K
Cost of Revenue
0
-100.0%
994
0
0
-100.0%
1.2K
Gross Profit
2.0K
1.8K
Operating Expenses
1.5M
-25.1%
1.9M
+53.0%
1.3M
+0.8%
1.3M
-24.0%
1.7M
R&D
541.7K
-1.5%
550.1K
+18.3%
465.2K
-7.2%
501.3K
-32.6%
743.3K
SG&A
888.6K
-35.0%
1.4M
+75.9%
776.8K
+6.2%
731.5K
-17.7%
888.4K
Operating Income
-1459153
+25.0%
-1945782
-52.8%
-1273034
-0.8%
-1263520
+23.9%
-1660478
EBITDA
-1430298
+25.3%
-1914833
-54.2%
-1241975
-0.7%
-1232778
+24.4%
-1629901
Net Income
-1403717
+25.6%
-1887674
-52.7%
-1235934
-0.2%
-1233303
+24.7%
-1638097
EPS (Basic)
$-0.38
+52.5%
$-0.80
-66.7%
$-0.48
+0.0%
$-0.48
+42.2%
$-0.83
EPS (Diluted)
$-0.38
+52.5%
$-0.80
-66.7%
$-0.48
+0.0%
$-0.48
+42.2%
$-0.83
Shares (Diluted)
3.7M
+55.3%
2.4M
-7.7%
2.6M
+0.0%
2.6M
+30.3%
2.0M
Creative Medical Technology (CELZ) — Financials